In January 2012, ChemGen Corporation was acquired by Elano - the animal health division of Eli Lilly and Company (NYSE: LLY). The firm i s designated a wholly owned subsiduary of Lilly and an operating unit of Elanco. Established in the mid-eighties, ChemGen had been a biotechnology company specializing in the production of enzymes through microbial fermentation. ChemGen's principle products are the patented poultry and swine feed additives Hemicell®, Hemicell® D and post pelleting enzyme application systems for liquid enzymes and vitamins. Other traditional feed enzymes (xylanase and glucanase) are also available from ChemGen for wheat and barley diets. The acquisition brought to Elanco a portfolio of leading feed enzyme products and a pipeline of innovative compounds in development. Retaining their facility in Gaitherburg, MD ChemGen for research and administrative operations, ChemGen also continued manufacturing activities at its facility in Terre Haute, IN.
